摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-acetyl-1,9-dibenzylpurin-6-one | 883977-31-9

中文名称
——
中文别名
——
英文名称
2-acetyl-1,9-dibenzylpurin-6-one
英文别名
——
2-acetyl-1,9-dibenzylpurin-6-one化学式
CAS
883977-31-9
化学式
C21H18N4O2
mdl
——
分子量
358.4
InChiKey
JEUMWWRPGFDZQR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    607.5±57.0 °C(Predicted)
  • 密度:
    1.27±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.89
  • 重原子数:
    27.0
  • 可旋转键数:
    5.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    69.78
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    描述:
    2-acetyl-1,9-dibenzylpurin-6-onesodium hydroxidesodium t-butanolate 作用下, 以 甲醇 为溶剂, 生成
    参考文献:
    名称:
    β-Diketo acids with purine nucleobase scaffolds: Novel, selective inhibitors of the strand transfer step of HIV integrase
    摘要:
    The HIV pol gene encodes three viral enzymes that are required for its replication. While drug discovery involving the viral targets, reverse transcriptase and protease, has resulted in useful therapeutic agents, such efforts on HIV integrase have not produced a single FDA-approved drug. In the work focused on the discovery of inhibitors of HIV integrase, we have synthesized new beta-diketo acids with purine nucleobase scaffolds that are potent inhibitors of the strand transfer steps of wild-type HIV-1 integrase. (C) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.12.093
  • 作为产物:
    描述:
    1,9-Dibenzyl-2-iodo-1,9-dihydro-purin-6-one盐酸 、 bis-triphenylphosphine-palladium(II) chloride 作用下, 以 N,N-二甲基甲酰胺丙酮 为溶剂, 生成 2-acetyl-1,9-dibenzylpurin-6-one
    参考文献:
    名称:
    β-Diketo acids with purine nucleobase scaffolds: Novel, selective inhibitors of the strand transfer step of HIV integrase
    摘要:
    The HIV pol gene encodes three viral enzymes that are required for its replication. While drug discovery involving the viral targets, reverse transcriptase and protease, has resulted in useful therapeutic agents, such efforts on HIV integrase have not produced a single FDA-approved drug. In the work focused on the discovery of inhibitors of HIV integrase, we have synthesized new beta-diketo acids with purine nucleobase scaffolds that are potent inhibitors of the strand transfer steps of wild-type HIV-1 integrase. (C) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.12.093
点击查看最新优质反应信息